Group One Trading
EVH icon

Group One Trading’s Evolent Health EVH Stock Holding History

Group One Trading’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.6K Sell
10,800
-3,900
-27% -$12.4K ﹤0.01% 5824
2025
Q4 		$58.8K Sell
14,700
-1,500
-9% -$8.34K ﹤0.01% 5468
2025
Q3 		$137K Buy
16,200
+10,600
+189% +$103K ﹤0.01% 5044
2025
Q2 		$63.1K Sell
5,600
-14,400
-72% -$132K ﹤0.01% 5380
2025
Q1 		$189K Sell
20,000
-269,400
-93% -$2.72M ﹤0.01% 4066
2024
Q4 		$3.26M Sell
289,400
-17,800
-6% -$313K 0.01% 1493
2024
Q3 		$8.69M Buy
307,200
+292,600
+2,004% +$7.54M 0.02% 679
2024
Q2 		$279K Sell
14,600
-9,400
-39% -$240K ﹤0.01% 3108
2024
Q1 		$787K Buy
24,000
+14,400
+150% +$460K ﹤0.01% 2302
2023
Q4 		$317K Buy
9,600
+7,900
+465% +$224K ﹤0.01% 3465
2023
Q3 		$46.3K Buy
1,700
+1,000
+143% +$27.8K ﹤0.01% 5173
2023
Q2 		$21.2K Sell
700
-27,000
-97% -$873K ﹤0.01% 5960
2023
Q1 		$899K Buy
27,700
+7,800
+39% +$247K ﹤0.01% 2227
2022
Q4 		$559K Buy
19,900
+14,100
+243% +$404K ﹤0.01% 2942
2022
Q3 		$208K Sell
5,800
-22,500
-80% -$793K ﹤0.01% 4111
2022
Q2 		$869K Sell
28,300
-3,500
-11% -$102K ﹤0.01% 2890
2022
Q1 		$1.03M Sell
31,800
-85,100
-73% -$2.23M ﹤0.01% 3039
2021
Q4 		$3.23M Sell
116,900
-60,600
-34% -$1.74M ﹤0.01% 2109
2021
Q3 		$5.5M Buy
177,500
+81,700
+85% +$1.96M 0.01% 1596
2021
Q2 		$2.02M Buy
95,800
+3,300
+4% +$66.1K ﹤0.01% 2634
2021
Q1 		$1.87M Buy
92,500
+32,900
+55% +$626K ﹤0.01% 2539
2020
Q4 		$955K Sell
59,600
-34,800
-37% -$460K ﹤0.01% 2681
2020
Q3 		$1.17M Buy
94,400
+40,700
+76% +$479K ﹤0.01% 2055
2020
Q2 		$382K Buy
53,700
+1,600
+3% +$10.7K ﹤0.01% 2851
2020
Q1 		$283K Buy
52,100
+38,500
+283% +$344K ﹤0.01% 2473
2019
Q4 		$123K Sell
13,600
-65,600
-83% -$533K ﹤0.01% 3506
2019
Q3 		$569K Buy
79,200
+69,100
+684% +$496K ﹤0.01% 2226
2019
Q2 		$80K Buy
+10,100
New +$120K ﹤0.01% 3515
2018
Q4 		– Sell
-600
Closed -$17K – 5000
2018
Q3 		$17K Buy
600
+100
+20% +$2.38K ﹤0.01% 4444
2018
Q2 		$11K Sell
500
-5,600
-92% -$106K ﹤0.01% 4580
2018
Q1 		$87K Buy
6,100
+4,800
+369% +$68.7K ﹤0.01% 3333
2017
Q4 		$16K Buy
1,300
+1,100
+550% +$15.5K ﹤0.01% 4221
2017
Q3 		$4K Sell
200
-11,500
-98% -$237K ﹤0.01% 4533
2017
Q2 		$297K Buy
11,700
+9,200
+368% +$221K ﹤0.01% 2352
2017
Q1 		$56K Sell
2,500
-2,000
-44% -$38.4K ﹤0.01% 3327
2016
Q4 		$67K Buy
4,500
+2,500
+125% +$49.3K ﹤0.01% 3076
2016
Q3 		$49K Buy
+2,000
New +$46.8K ﹤0.01% 3360

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's EVH Position: Q1 2026 in Review

Group One Trading sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 3,591 shares — an estimated $11.4K sold.

Group One Trading first reported a position in EVH in Q4 2015 and held it in 27 quarters. The position peaked at $3.8M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Group One Trading reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,591 Evolent Health shares in Q1 2026, an estimated $11.4K.
  • Group One Trading first reported a position in Evolent Health in Q4 2015 and held it in 27 quarters.
  • Group One Trading's Evolent Health position peaked at $3.8M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.